Richard J Hawkins
CIK 1307632 · Chief Executive Officer · last filed 2026-07-01
Richard J Hawkins is a Chief Executive Officer who has filed 76 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for PSTV, was dated Jul 1, 2026. Across all open-market trades the lifetime net is −$1.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $865.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$865.6K
5
76
-$1.05M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PSTV | Director | 1,529 | $3.76 | $5.7K | $25.5K | 13 | 2026-07-01 |
| SVRA | Director | 161,326 | $5.33 | $859.9K | -$205.6K | 14 | 2025-12-11 |
| LUMOS PHARMA, INC. (LUMO) Delisted | Chief Executive Officer | 0 | $4.34 | $0 | $39.3K | 12 | 2024-12-13 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | 8,435 | — | — | $0 | 15 | 2017-11-29 |
| SCICLONE PHARMACEUTICALS INC (SCLN) Delisted | Director | 0 | — | — | -$908.5K | 20 | 2017-10-16 |
Recent Filings
76 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-01 | PSTV | Exer (M) | +922 | $0 | EDGAR |
| 2026-05-18 | PSTV | Grant (A) | — | $0 | EDGAR |
| 2025-12-11 | SVRA | Grant (A) | +40,000 | $0 | EDGAR |
| 2025-11-17 | SVRA | Exer (M) | +5,860 | $8.6K | EDGAR |
| 2025-08-15 | PSTV | Grant (A) | — | $0 | EDGAR |
| 2025-06-23 | SVRA | Buy (P) | +48,225 | $98.6K | EDGAR |
| 2025-02-20 | PSTV | Grant (A) | — | $0 | EDGAR |
| 2024-12-16 | SVRA | Notice (144) | −8,000 | -$26.3K | EDGAR |
| 2024-12-16 | SVRA | Mixed | +32,000 | -$26.6K | EDGAR |
| 2024-12-13 | LUMOS PHARMA, INC. (LUMO) Delisted | Disp (D) | −757,562 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.